Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

How do migrants in crisis feel about intensive care? a new study aims to find out

NCT ID NCT07204626

Knowledge-focused Sponsor: Centre Hospitalier de Saint-Denis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how migrants with low income or unstable living situations experience being in the intensive care unit (ICU) and their recovery afterward. Researchers will interview 100 patients in France to understand their views and feelings about their health and hospital care. The goal is to learn how to better support this group during critical illness and recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adult migrant patients (≥18 years old) hospitalized in intensive care units (ICU) and receiving post-ICU rehabilitation care (SRPR) in selected French hospitals (Saint-Denis, Gonesse, Avicenne, Bichat). Eligible patients include those born outside France, regardless of their date of arrival, length of residence, or nationality, and who are able to communicate in French, Spanish, or Italian, either directly or via professional interpretation or cultural mediation. Participants must have a psychological and neurological state compatible with providing informed consent and participating in interviews.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: For patients: Male and female migrants (born outside of France and its territories, regardless of date of arrival, length of residence, or acquired nationality) Aged 18 years or older Living in or transiting through France With or without residence permits or legal documentation Hospitalized in ICUs and receiving care in post-ICU rehabilitation units (SRPR) Providing consent to participate in the study Having good proficiency in French, Spanish, or Italian, or, if not, benefiting from professional interpretation (ISM) or cultural mediation ensuring effective communication Having a psychological and neurological state compatible with providing informed consent and taking part in an interview For healthcare professionals and associative actors: Being a healthcare, social work, or associative professional Involved in the medical, psycho-social, and/or legal support and care of migrant patients admitted to ICUs and SRPR Providing consent to participate in the study Exclusion Criteria: For patients: Being born in France Being a minor (\<18 years old) Being under guardianship or curatorship Having a neurological state incompatible with providing informed consent and taking part in an interview For healthcare professionals and associative actors: Not being involved in the care of migrant patients admitted to ICUs and SRPR

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anthropology are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anthropology Immigrant Intensive care (ICU) Precariousness

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier de Saint-Denis

    Saint-Denis, France, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.